Decision Resources

Infra Redx, based in Burlington, MA, is a pioneering company dedicated to developing advanced solutions for vascular disease, particularly focusing on coronary artery disease. Their innovative products, such as the Makoto Intravascular Imaging platform and Clarispro HDIVUS, combine high-resolution imaging with plaque compositional analysis to provide critical insights for treatment. The company emphasizes the importance of identifying unstable lipid core plaques that can lead to major adverse cardiac events, as demonstrated in studies like the YELLOW III Study. With a commitment to enhancing patient care through cutting-edge technology, Infra Redx is at the forefront of improving cardiovascular health outcomes. Generated from the website

N of One is a leading company based in Lexington, Town of, MA, specializing in powerful digital insights and solutions for discovery and research in the fields of genomics and biomarker discovery. Their comprehensive range of products and services includes clinical NGS testing, clinical testing solutions, and interpretation and visualization tools, all designed to help researchers and clinical labs make impactful discoveries and deliver patient-specific reports efficiently. With a focus on innovation and integration, N of One offers a wide range of solutions for various applications, including oncology, inherited disorders, rare undiagnosed diseases, and cardiac disorders. Their expertise in molecular intelligence and augmented decision support software enables clinical labs to make faster and more accurate decisions, ultimately improving patient outcomes. N of One's commitment to knowledge and databases, such as QIAGEN Biomedical Knowledge Base and Gene Variant Databases, ensures reliable and trustworthy data for solving complex cases and identifying disease-causing mutations.Generated from the website

Translate Bio is a biotechnology company based in Lexington, MA that focuses on developing mRNA therapeutics for various diseases. The company's research and development efforts are centered around leveraging mRNA technology to create potential treatments for a range of medical conditions. Translate Bio's work in the field of mRNA therapeutics aims to address unmet medical needs and advance the understanding of this innovative approach to healthcare. Through its research initiatives, the company seeks to contribute to the advancement of personalized medicine and improve patient outcomes. Generated from their business information